OJBIPHY  Vol.2 No.4 , October 2012
Radiation Exposure of Leukemia Blood Samples and Its Impacts on the Density of RBC, WBC, and PLT: In Vitro
ABSTRACT
Complete blood counts were analyzed for 12 samples (six male & six female: Ages 15-40 years) of leukemia blood Samples for different dose rate and time of exposure using a Radium-226 source. Thus, an optimum time of exposure and exposure dose rate has improved for leukemia blood samples. Blood samples fractionated and placed in plastic wills, and melodic Coulter used to analysis exposed leukemia blood samples before and after exposure. Exposure technique involving CR-39 nuclear track detector and radiation survey dosimeter were used to estimate the alpha particle density incident on the blood samples and the exposed dose rate, respectively. In the first part, density of the accumulation of alpha particle on the surface of leukemia blood samples, and on the surface of CR-39NTDs varies exponentially with the exposed dose rate. This depends on the restricted energy loss of the incident alpha particles and target density. Assess an optimum time of exposure dose rate (1100 μSv/h) was the second objective. This depended on the changes in the blood components (PLT, WBC, and RBC) due to irradiation occurred for different durations of irradia-tion, and the duration of irradiation that influenced the leukemia blood samples (1Male; 16 year and one Female 17 years) in this research was five minutes. Changes in the density of PLT, WBC, and RBC for leukemia blood samples and for different male (five male) and females (five female) was the third part of this research. It was found that the changes were variables due to the exposed dose rate. Optimum exposed dose rate to make more effects on the cancer cells for the leukemia blood samples began at the radiation dose rate of 43.25 1.206 μSv/h for both; male and female relatively, and this due to chromosomal aberration of the exposed cells. Finally, comparison study with the healthy blood samples has been investigated. More details are listed and clarified in the tables and figures of this paper.

Cite this paper
A. Ismail, M. Hamad and E. Harki, "Radiation Exposure of Leukemia Blood Samples and Its Impacts on the Density of RBC, WBC, and PLT: In Vitro," Open Journal of Biophysics, Vol. 2 No. 4, 2012, pp. 130-136. doi: 10.4236/ojbiphy.2012.24016.
References
[1]   R. J. Dufrain, L. G. Littlefield and E. E. Joiner, “Human Cytogenetic Dosimetry: A Dose Response Relationship for Alpha Particle Radiation from 241Am,” Health Physics, Vol. 37, No. 3, 1979, pp. 279-289. Hdoi:10.1097/00004032-197909000-00002

[2]   NRCNA (National Research Council of the National Academies), “Health Risks from Exposure to Low Levels of Ionizing Radiation,” Beir VII Phase 2, 2006.

[3]   R. W. Field, “Radon: An Overview of Health Effects,” Encyclopedia of Environmental Health, Vol. 23, 2011, pp.745-753.

[4]   M. E. Gaulden, “Biological Dosimetry of Radionuclide and Radiation Hazards,” Journal of Nuclear Medicine, Vol. 24, No. 2, 1983, pp. 160-164.

[5]   R. M. Anderson, S. J. Marsden, E. G. Wright, M. A. Kadhim, D. T. Goodhead and C. S. Griffin, “Complex Chromosome Aberrations in Peripheral Blood Lymphocytes as a Potential Biomarker of Exposure to High-LET Alpha-Particles,” International Journal of Radiation Biology, Vol. 76, No. 1, 2000, pp. 31-42. Hdoi:10.1080/095530000138989

[6]   A. H. Ismail and M. S. Jaafar, “Interaction of Low-Intensity Nuclear Radiation Dose with the Human Blood: Using the New Technique of CR-39NTDs for an in Vitro Study,” Applied Radiation and Isotopes, Vol. 69, No. 3, 2011, pp. 559-566. Hdoi:10.1016/j.apradiso.2010.11.004

[7]   IAEA (International Atomic Energy Agency), “Effects of Ionizing Radiation on Blood and Blood Components: A Survey,” TECDOC-934, 1997.

[8]   ICRP (International Commission on Radiological Pro tection), “Recommendation of the International Commission on Radiological Protection,” ICRP Publication 60, 1990, pp. 1-3.

[9]   K. Cureton, B. Phillip, H. Patricia, N. Hillary, V. Susan and Z. Linda, “Sex Difference in Maximal Oxygen Up take; Effect of Equating Hemoglobin Concentration,” European Journal of Applied Physiology, Vol. 54, No. 6, 1986, pp. 656-660. Hdoi:10.1007/BF00943356

[10]   A. A. Edwards, R. J. Purrott, S. J. Prosser and D. C. Lloyd, “The Induction of Chromosome Aberrations In Human Lymphocytes by Alpha-Radiation,” International Journal of Radiation Biology & Related Studies in Physics, Chemistry & Medicine, Vol. 38, No. 1, 1980, pp. 83-91.

[11]   V. Z. Hamza, P. R. V. Kumar, R. K. Jeevanram, R. San tanam and B. Danalaksmi, “A Simple Method to Irradiate Blood Cells in Vitro with Radon Gas,” Radiation Protection Dosimetry, Vol. 130, No. 3, 2008, pp. 343-350. Hdoi:10.1093/rpd/ncn060

[12]   T. Kenner, “Review: The Measurement of Blood Density and Its Meaning,” Basic Research in Cardiology, Vol. 84, No. 2, 1989, pp. 111-124. Hdoi:10.1007/BF01907921

[13]   V. Valkovi?, “Radiation Safety,” Radioactivity in the Environment, Vol. 23, 2000, pp. 259-303.| Hdoi:10.1016/B978-044482954-2/50006-X

[14]   M. Hada, W. U. Honglu and F. A. Cucinotta, “mBAND Analysis for High-and Low-LET Radiation Induced Chro- mosome Aberrations: A Review,” Mutation Research/ Fundamental and Molecular Mechanisms of Mutagenesis, 2011.

[15]   K. Jefferson, “Radiation Worker I Training Study Guide,” Lab Radiation Control Department, 2010, pp. 1-73.

[16]   G. Sgouros, “Alpha-Particles for Targeted Therapy,” Advanced Drug Delivery Reviews, Vol. 60, No. 12, 2008, pp. 1402-1406. Hdoi:10.1016/j.addr.2008.04.007

[17]   N. Joseph and J. Phalen, “Online Radiology Continuing Education for Radiology Professionals. Part 2. Biological Effects of Irradiation,” 2010. http://www.ceessentials.net/article3.html

[18]   D. C. Lloyd, R. J. Purrott, G. W. Dolphin, D. Bolton, A. A. Edwards and M. J. Corp, “The Relationship between Chromosome Aberrations and Low LET Radiation Dose to Human Lymphocytes,” International Journal of Radiation and Biology, Vol. 28, No. 1, 1975, pp. 75-90. Hdoi:10.1080/09553007514550781

[19]   S. C. Mehta, “Health Risks of Low Level Radiation Exposures: A Review,” Indian Journal of Nuclear Medicine, Vol. 20, No. 2, 2005, pp. 29-41.

[20]   J. Pohl-Ruling and E. Pohl, “Method for Alpha Irradiation of Blood Cultures with Short-Lived Radon-222 Decay Products,” Mutation Research, Vol. 234, No. 5, 1990, pp. 43-45. Hdoi:10.1016/0165-1161(90)90029-N

[21]   J. Pohl-Ruling, H. Lettner, W. Hofmann, P. Eckl, O. A. Haas, et al., “Chromosomal Aberrations of Blood Lymphocytes Induced in Vitro by Radon-222 Daughter α-Ir- radiation,” Mutation Research, Vol. 449, No. 1-2, 2000, pp. 7-19. Hdoi:10.1016/S0027-5107(00)00009-9

 
 
Top